E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/23/2021 in the Prospect News Structured Products Daily.

New Issue: UBS prices $370,000 return optimization securities on Exact Sciences

New York, Sept. 23 – UBS AG, London Branch priced $370,000 of return optimization securities due Sept. 20, 2022 linked to the common stock of Exact Sciences Corp., according to a 424B2 filing with the Securities and Exchange Commission.

If Exact Sciences stock closes at or above the initial price, the payout at maturity will be par plus two times any gain in common stock of Exact Sciences capped at 40.56%.

Investors will share in any losses.

UBS Financial Services Inc. and UBS Investment Bank are the underwriters.

Issuer:UBS AG, London Branch
Issue:Return optimization securities
Underlying stock:Exact Sciences Corp. (Nasdaq: EXAS)
Amount:$370,000
Maturity:Sept. 20, 2022
Coupon:0%
Price:Par of $10
Payout at maturity:Par plus two times any gain in common stock of Exact Sciences, capped at 40.56%; otherwise, exposure to any losses
Initial share price:$104.65
Pricing date:Sept. 15
Settlement date:Sept. 17
Underwriters:UBS Financial Services Inc. and UBS Investment Bank
Fees:1%
Cusip:90300Y632

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.